img

Global Small Molecule CDMO Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Small Molecule CDMO Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Small Molecule CDMO Market
Global Small Molecule CDMO market is expected to reach to US$ 1258 million in 2023, with a positive growth of %, compared with US$ 1162 million in 2022. Backed with the increasing demand from downstream industries, Small Molecule CDMO industry is evaluated to reach US$ 2417.3 million in 2033. The CAGR will be 11.5% during 2023 to 2033.
Globally, Small Molecule CDMO key companies include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. Lonza, Catalent, Thermo Fisher are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Small Molecule CDMO were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Small Molecule CDMO market and estimated to attract more attentions from industry insiders and investors.
Small Molecule CDMO can be divided into Development and API Production, etc. Development is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Small Molecule CDMO is widely used in various fields, such as Pharmaceutical and Biotechnology, etc. Pharmaceutical provides greatest supports to the Small Molecule CDMO industry development. In 2022, global % revenue of Small Molecule CDMO went into Pharmaceutical filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Small Molecule CDMO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Small Molecule CDMO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type
Development
API Production

Segment by Application


Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Small Molecule CDMO introduction, etc. Small Molecule CDMO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Small Molecule CDMO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Development
1.2.3 API Production
1.3 Market by Application
1.3.1 Global Small Molecule CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CDMO Market Perspective (2018-2033)
2.2 Global Small Molecule CDMO Growth Trends by Region
2.2.1 Small Molecule CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Small Molecule CDMO Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule CDMO Forecasted Market Size by Region (2024-2033)
2.3 Small Molecule CDMO Market Dynamics
2.3.1 Small Molecule CDMO Industry Trends
2.3.2 Small Molecule CDMO Market Drivers
2.3.3 Small Molecule CDMO Market Challenges
2.3.4 Small Molecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Small Molecule CDMO by Players
3.1.1 Global Small Molecule CDMO Revenue by Players (2018-2023)
3.1.2 Global Small Molecule CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Small Molecule CDMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Small Molecule CDMO Market Concentration Ratio
3.4.1 Global Small Molecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CDMO Revenue in 2022
3.5 Global Key Players of Small Molecule CDMO Head office and Area Served
3.6 Global Key Players of Small Molecule CDMO, Product and Application
3.7 Global Key Players of Small Molecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CDMO Breakdown Data by Type
4.1 Global Small Molecule CDMO Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule CDMO Forecasted Market Size by Type (2024-2033)
5 Small Molecule CDMO Breakdown Data by Application
5.1 Global Small Molecule CDMO Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Small Molecule CDMO Market Size (2018-2033)
6.2 North America Small Molecule CDMO Market Size by Type
6.2.1 North America Small Molecule CDMO Market Size by Type (2018-2023)
6.2.2 North America Small Molecule CDMO Market Size by Type (2024-2033)
6.2.3 North America Small Molecule CDMO Market Share by Type (2018-2033)
6.3 North America Small Molecule CDMO Market Size by Application
6.3.1 North America Small Molecule CDMO Market Size by Application (2018-2023)
6.3.2 North America Small Molecule CDMO Market Size by Application (2024-2033)
6.3.3 North America Small Molecule CDMO Market Share by Application (2018-2033)
6.4 North America Small Molecule CDMO Market Size by Country
6.4.1 North America Small Molecule CDMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Small Molecule CDMO Market Size by Country (2018-2023)
6.4.3 North America Small Molecule CDMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Small Molecule CDMO Market Size (2018-2033)
7.2 Europe Small Molecule CDMO Market Size by Type
7.2.1 Europe Small Molecule CDMO Market Size by Type (2018-2023)
7.2.2 Europe Small Molecule CDMO Market Size by Type (2024-2033)
7.2.3 Europe Small Molecule CDMO Market Share by Type (2018-2033)
7.3 Europe Small Molecule CDMO Market Size by Application
7.3.1 Europe Small Molecule CDMO Market Size by Application (2018-2023)
7.3.2 Europe Small Molecule CDMO Market Size by Application (2024-2033)
7.3.3 Europe Small Molecule CDMO Market Share by Application (2018-2033)
7.4 Europe Small Molecule CDMO Market Size by Country
7.4.1 Europe Small Molecule CDMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Small Molecule CDMO Market Size by Country (2018-2023)
7.4.3 Europe Small Molecule CDMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Small Molecule CDMO Market Size (2018-2033)
8.2 China Small Molecule CDMO Market Size by Type
8.2.1 China Small Molecule CDMO Market Size by Type (2018-2023)
8.2.2 China Small Molecule CDMO Market Size by Type (2024-2033)
8.2.3 China Small Molecule CDMO Market Share by Type (2018-2033)
8.3 China Small Molecule CDMO Market Size by Application
8.3.1 China Small Molecule CDMO Market Size by Application (2018-2023)
8.3.2 China Small Molecule CDMO Market Size by Application (2024-2033)
8.3.3 China Small Molecule CDMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Small Molecule CDMO Market Size (2018-2033)
9.2 Asia Small Molecule CDMO Market Size by Type
9.2.1 Asia Small Molecule CDMO Market Size by Type (2018-2023)
9.2.2 Asia Small Molecule CDMO Market Size by Type (2024-2033)
9.2.3 Asia Small Molecule CDMO Market Share by Type (2018-2033)
9.3 Asia Small Molecule CDMO Market Size by Application
9.3.1 Asia Small Molecule CDMO Market Size by Application (2018-2023)
9.3.2 Asia Small Molecule CDMO Market Size by Application (2024-2033)
9.3.3 Asia Small Molecule CDMO Market Share by Application (2018-2033)
9.4 Asia Small Molecule CDMO Market Size by Region
9.4.1 Asia Small Molecule CDMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Small Molecule CDMO Market Size by Region (2018-2023)
9.4.3 Asia Small Molecule CDMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Small Molecule CDMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Small Molecule CDMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Small Molecule CDMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Small Molecule CDMO Introduction
11.1.4 Lonza Revenue in Small Molecule CDMO Business (2018-2023)
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule CDMO Introduction
11.2.4 Catalent Revenue in Small Molecule CDMO Business (2018-2023)
11.2.5 Catalent Recent Developments
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Small Molecule CDMO Introduction
11.3.4 Thermo Fisher Revenue in Small Molecule CDMO Business (2018-2023)
11.3.5 Thermo Fisher Recent Developments
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Details
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CDMO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CDMO Business (2018-2023)
11.4.5 Wuxi Apptec Recent Developments
11.5 PharmaBlock
11.5.1 PharmaBlock Company Details
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CDMO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CDMO Business (2018-2023)
11.5.5 PharmaBlock Recent Developments
11.6 Asym Chemical
11.6.1 Asym Chemical Company Details
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CDMO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CDMO Business (2018-2023)
11.6.5 Asym Chemical Recent Developments
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Details
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2018-2023)
11.7.5 Jiuzhou Pharmaceutical Recent Developments
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Details
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CDMO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CDMO Business (2018-2023)
11.8.5 Pharmaron Beijing Recent Developments
11.9 Porton Pharma
11.9.1 Porton Pharma Company Details
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CDMO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CDMO Business (2018-2023)
11.9.5 Porton Pharma Recent Developments
11.10 ChemPartner
11.10.1 ChemPartner Company Details
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CDMO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CDMO Business (2018-2023)
11.10.5 ChemPartner Recent Developments
11.11 Jiangsu Sinopep
11.11.1 Jiangsu Sinopep Company Details
11.11.2 Jiangsu Sinopep Business Overview
11.11.3 Jiangsu Sinopep Small Molecule CDMO Introduction
11.11.4 Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2018-2023)
11.11.5 Jiangsu Sinopep Recent Developments
11.12 DELPHARM
11.12.1 DELPHARM Company Details
11.12.2 DELPHARM Business Overview
11.12.3 DELPHARM Small Molecule CDMO Introduction
11.12.4 DELPHARM Revenue in Small Molecule CDMO Business (2018-2023)
11.12.5 DELPHARM Recent Developments
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Small Molecule CDMO Introduction
11.13.4 Aenova Group Revenue in Small Molecule CDMO Business (2018-2023)
11.13.5 Aenova Group Recent Developments
11.14 Siegfried Holding AG
11.14.1 Siegfried Holding AG Company Details
11.14.2 Siegfried Holding AG Business Overview
11.14.3 Siegfried Holding AG Small Molecule CDMO Introduction
11.14.4 Siegfried Holding AG Revenue in Small Molecule CDMO Business (2018-2023)
11.14.5 Siegfried Holding AG Recent Developments
11.15 Recipharm AB
11.15.1 Recipharm AB Company Details
11.15.2 Recipharm AB Business Overview
11.15.3 Recipharm AB Small Molecule CDMO Introduction
11.15.4 Recipharm AB Revenue in Small Molecule CDMO Business (2018-2023)
11.15.5 Recipharm AB Recent Developments
11.16 FAREVA SA
11.16.1 FAREVA SA Company Details
11.16.2 FAREVA SA Business Overview
11.16.3 FAREVA SA Small Molecule CDMO Introduction
11.16.4 FAREVA SA Revenue in Small Molecule CDMO Business (2018-2023)
11.16.5 FAREVA SA Recent Developments
11.17 Almac Group
11.17.1 Almac Group Company Details
11.17.2 Almac Group Business Overview
11.17.3 Almac Group Small Molecule CDMO Introduction
11.17.4 Almac Group Revenue in Small Molecule CDMO Business (2018-2023)
11.17.5 Almac Group Recent Developments
11.18 Cambrex
11.18.1 Cambrex Company Details
11.18.2 Cambrex Business Overview
11.18.3 Cambrex Small Molecule CDMO Introduction
11.18.4 Cambrex Revenue in Small Molecule CDMO Business (2018-2023)
11.18.5 Cambrex Recent Developments
11.19 Charles River
11.19.1 Charles River Company Details
11.19.2 Charles River Business Overview
11.19.3 Charles River Small Molecule CDMO Introduction
11.19.4 Charles River Revenue in Small Molecule CDMO Business (2018-2023)
11.19.5 Charles River Recent Developments
11.20 CORDEN PHARMA
11.20.1 CORDEN PHARMA Company Details
11.20.2 CORDEN PHARMA Business Overview
11.20.3 CORDEN PHARMA Small Molecule CDMO Introduction
11.20.4 CORDEN PHARMA Revenue in Small Molecule CDMO Business (2018-2023)
11.20.5 CORDEN PHARMA Recent Developments
11.21 Jubilant Pharmova
11.21.1 Jubilant Pharmova Company Details
11.21.2 Jubilant Pharmova Business Overview
11.21.3 Jubilant Pharmova Small Molecule CDMO Introduction
11.21.4 Jubilant Pharmova Revenue in Small Molecule CDMO Business (2018-2023)
11.21.5 Jubilant Pharmova Recent Developments
11.22 Consort Medical
11.22.1 Consort Medical Company Details
11.22.2 Consort Medical Business Overview
11.22.3 Consort Medical Small Molecule CDMO Introduction
11.22.4 Consort Medical Revenue in Small Molecule CDMO Business (2018-2023)
11.22.5 Consort Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Small Molecule CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Development
Table 3. Key Players of API Production
Table 4. Global Small Molecule CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Small Molecule CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Small Molecule CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Small Molecule CDMO Market Share by Region (2018-2023)
Table 8. Global Small Molecule CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Small Molecule CDMO Market Share by Region (2024-2033)
Table 10. Small Molecule CDMO Market Trends
Table 11. Small Molecule CDMO Market Drivers
Table 12. Small Molecule CDMO Market Challenges
Table 13. Small Molecule CDMO Market Restraints
Table 14. Global Small Molecule CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Small Molecule CDMO Revenue Share by Players (2018-2023)
Table 16. Global Top Small Molecule CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2022)
Table 17. Global Small Molecule CDMO Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Small Molecule CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Small Molecule CDMO, Headquarters and Area Served
Table 20. Global Key Players of Small Molecule CDMO, Product and Application
Table 21. Global Key Players of Small Molecule CDMO, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Small Molecule CDMO Revenue Market Share by Type (2018-2023)
Table 25. Global Small Molecule CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Small Molecule CDMO Revenue Market Share by Type (2024-2033)
Table 27. Global Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Small Molecule CDMO Revenue Share by Application (2018-2023)
Table 29. Global Small Molecule CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Small Molecule CDMO Revenue Share by Application (2024-2033)
Table 31. North America Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Small Molecule CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Small Molecule CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Small Molecule CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Small Molecule CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Small Molecule CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Small Molecule CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Small Molecule CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Small Molecule CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Small Molecule CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Small Molecule CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Small Molecule CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Small Molecule CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Small Molecule CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Small Molecule CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Small Molecule CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Small Molecule CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Small Molecule CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Small Molecule CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Small Molecule CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 63. Lonza Company Details
Table 64. Lonza Business Overview
Table 65. Lonza Small Molecule CDMO Product
Table 66. Lonza Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 67. Lonza Recent Developments
Table 68. Catalent Company Details
Table 69. Catalent Business Overview
Table 70. Catalent Small Molecule CDMO Product
Table 71. Catalent Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 72. Catalent Recent Developments
Table 73. Thermo Fisher Company Details
Table 74. Thermo Fisher Business Overview
Table 75. Thermo Fisher Small Molecule CDMO Product
Table 76. Thermo Fisher Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 77. Thermo Fisher Recent Developments
Table 78. Wuxi Apptec Company Details
Table 79. Wuxi Apptec Business Overview
Table 80. Wuxi Apptec Small Molecule CDMO Product
Table 81. Wuxi Apptec Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 82. Wuxi Apptec Recent Developments
Table 83. PharmaBlock Company Details
Table 84. PharmaBlock Business Overview
Table 85. PharmaBlock Small Molecule CDMO Product
Table 86. PharmaBlock Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 87. PharmaBlock Recent Developments
Table 88. Asym Chemical Company Details
Table 89. Asym Chemical Business Overview
Table 90. Asym Chemical Small Molecule CDMO Product
Table 91. Asym Chemical Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 92. Asym Chemical Recent Developments
Table 93. Jiuzhou Pharmaceutical Company Details
Table 94. Jiuzhou Pharmaceutical Business Overview
Table 95. Jiuzhou Pharmaceutical Small Molecule CDMO Product
Table 96. Jiuzhou Pharmaceutical Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 97. Jiuzhou Pharmaceutical Recent Developments
Table 98. Pharmaron Beijing Company Details
Table 99. Pharmaron Beijing Business Overview
Table 100. Pharmaron Beijing Small Molecule CDMO Product
Table 101. Pharmaron Beijing Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 102. Pharmaron Beijing Recent Developments
Table 103. Porton Pharma Company Details
Table 104. Porton Pharma Business Overview
Table 105. Porton Pharma Small Molecule CDMO Product
Table 106. Porton Pharma Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 107. Porton Pharma Recent Developments
Table 108. ChemPartner Company Details
Table 109. ChemPartner Business Overview
Table 110. ChemPartner Small Molecule CDMO Product
Table 111. ChemPartner Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 112. ChemPartner Recent Developments
Table 113. Jiangsu Sinopep Company Details
Table 114. Jiangsu Sinopep Business Overview
Table 115. Jiangsu Sinopep Small Molecule CDMO Product
Table 116. Jiangsu Sinopep Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 117. Jiangsu Sinopep Recent Developments
Table 118. DELPHARM Company Details
Table 119. DELPHARM Business Overview
Table 120. DELPHARM Small Molecule CDMO Product
Table 121. DELPHARM Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 122. DELPHARM Recent Developments
Table 123. Aenova Group Company Details
Table 124. Aenova Group Business Overview
Table 125. Aenova Group Small Molecule CDMO Product
Table 126. Aenova Group Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 127. Aenova Group Recent Developments
Table 128. Siegfried Holding AG Company Details
Table 129. Siegfried Holding AG Business Overview
Table 130. Siegfried Holding AG Small Molecule CDMO Product
Table 131. Siegfried Holding AG Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 132. Siegfried Holding AG Recent Developments
Table 133. Recipharm AB Company Details
Table 134. Recipharm AB Business Overview
Table 135. Recipharm AB Small Molecule CDMO Product
Table 136. Recipharm AB Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 137. Recipharm AB Recent Developments
Table 138. FAREVA SA Company Details
Table 139. FAREVA SA Business Overview
Table 140. FAREVA SA Small Molecule CDMO Product
Table 141. FAREVA SA Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 142. FAREVA SA Recent Developments
Table 143. Almac Group Company Details
Table 144. Almac Group Business Overview
Table 145. Almac Group Small Molecule CDMO Product
Table 146. Almac Group Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 147. Almac Group Recent Developments
Table 148. Cambrex Company Details
Table 149. Cambrex Business Overview
Table 150. Cambrex Small Molecule CDMO Product
Table 151. Cambrex Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 152. Cambrex Recent Developments
Table 153. Charles River Company Details
Table 154. Charles River Business Overview
Table 155. Charles River Small Molecule CDMO Product
Table 156. Charles River Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 157. Charles River Recent Developments
Table 158. CORDEN PHARMA Company Details
Table 159. CORDEN PHARMA Business Overview
Table 160. CORDEN PHARMA Small Molecule CDMO Product
Table 161. CORDEN PHARMA Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 162. CORDEN PHARMA Recent Developments
Table 163. Jubilant Pharmova Company Details
Table 164. Jubilant Pharmova Business Overview
Table 165. Jubilant Pharmova Small Molecule CDMO Product
Table 166. Jubilant Pharmova Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 167. Jubilant Pharmova Recent Developments
Table 168. Consort Medical Company Details
Table 169. Consort Medical Business Overview
Table 170. Consort Medical Small Molecule CDMO Product
Table 171. Consort Medical Revenue in Small Molecule CDMO Business (2018-2023) & (US$ Million)
Table 172. Consort Medical Recent Developments
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Small Molecule CDMO Market Share by Type: 2022 VS 2033
Figure 3. Development Features
Figure 4. API Production Features
Figure 5. Global Small Molecule CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Small Molecule CDMO Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Case Studies
Figure 8. Biotechnology Case Studies
Figure 9. Small Molecule CDMO Report Years Considered
Figure 10. Global Small Molecule CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Small Molecule CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Small Molecule CDMO Market Share by Region: 2022 VS 2033
Figure 13. Global Small Molecule CDMO Market Share by Players in 2022
Figure 14. Global Top Small Molecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Small Molecule CDMO Revenue in 2022
Figure 16. North America Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Small Molecule CDMO Market Share by Type (2018-2033)
Figure 18. North America Small Molecule CDMO Market Share by Application (2018-2033)
Figure 19. North America Small Molecule CDMO Market Share by Country (2018-2033)
Figure 20. United States Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Small Molecule CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe Small Molecule CDMO Market Share by Type (2018-2033)
Figure 24. Europe Small Molecule CDMO Market Share by Application (2018-2033)
Figure 25. Europe Small Molecule CDMO Market Share by Country (2018-2033)
Figure 26. Germany Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China Small Molecule CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China Small Molecule CDMO Market Share by Type (2018-2033)
Figure 34. China Small Molecule CDMO Market Share by Application (2018-2033)
Figure 35. Asia Small Molecule CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia Small Molecule CDMO Market Share by Type (2018-2033)
Figure 37. Asia Small Molecule CDMO Market Share by Application (2018-2033)
Figure 38. Asia Small Molecule CDMO Market Share by Region (2018-2033)
Figure 39. Japan Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Small Molecule CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Small Molecule CDMO Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America Small Molecule CDMO Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America Small Molecule CDMO Market Share by Country (2018-2033)
Figure 49. Brazil Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries Small Molecule CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Lonza Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 56. Catalent Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 57. Thermo Fisher Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 58. Wuxi Apptec Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 59. PharmaBlock Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 60. Asym Chemical Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 61. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 62. Pharmaron Beijing Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 63. Porton Pharma Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 64. ChemPartner Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 65. Jiangsu Sinopep Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 66. DELPHARM Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 67. Aenova Group Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 68. Siegfried Holding AG Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 69. Recipharm AB Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 70. FAREVA SA Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 71. Almac Group Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 72. Cambrex Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 73. Charles River Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 74. CORDEN PHARMA Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 75. Jubilant Pharmova Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 76. Consort Medical Revenue Growth Rate in Small Molecule CDMO Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed